Gotham Asset Management LLC Cuts Stake in Masimo Co. (NASDAQ:MASI)

Gotham Asset Management LLC lessened its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 16.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 127,780 shares of the medical equipment provider's stock after selling 25,706 shares during the quarter. Gotham Asset Management LLC owned approximately 0.24% of Masimo worth $21,122,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Barclays PLC raised its position in shares of Masimo by 152.6% during the third quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider's stock worth $5,329,000 after purchasing an additional 24,137 shares during the period. Tidal Investments LLC purchased a new position in Masimo in the third quarter valued at about $319,000. GAMMA Investing LLC raised its stake in shares of Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider's stock valued at $77,000 after buying an additional 269 shares during the period. Nordea Investment Management AB lifted its holdings in Masimo by 0.7% during the fourth quarter. Nordea Investment Management AB now owns 19,182 shares of the medical equipment provider's stock valued at $3,206,000 after purchasing an additional 142 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC purchased a new position in Masimo in the 4th quarter valued at approximately $241,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Up 0.4%

NASDAQ:MASI traded up $0.72 during mid-day trading on Tuesday, hitting $164.28. 29,667 shares of the company's stock traded hands, compared to its average volume of 657,858. The company has a fifty day moving average of $161.21 and a 200 day moving average of $167.10. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $194.88. The company has a market capitalization of $8.91 billion, a P/E ratio of 113.56 and a beta of 1.23.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, beating the consensus estimate of $1.24 by $0.12. The firm had revenue of $372.00 million during the quarter, compared to analyst estimates of $367.79 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. Masimo's revenue was down 24.5% on a year-over-year basis. During the same period last year, the firm posted $0.77 EPS. On average, analysts forecast that Masimo Co. will post 4.1 EPS for the current year.

Wall Street Analysts Forecast Growth

MASI has been the topic of a number of research analyst reports. BTIG Research set a $193.00 price target on shares of Masimo and gave the stock a "buy" rating in a report on Wednesday, May 7th. Raymond James cut their price objective on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. Piper Sandler restated an "overweight" rating and set a $200.00 price objective (down from $215.00) on shares of Masimo in a research note on Wednesday, May 7th. Wells Fargo & Company decreased their target price on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research note on Wednesday, May 7th. Finally, Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Masimo currently has an average rating of "Moderate Buy" and a consensus target price of $191.60.

Insiders Place Their Bets

In related news, Director Craig B. Reynolds sold 2,053 shares of Masimo stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the sale, the director now directly owns 16,581 shares in the company, valued at approximately $2,754,601.53. The trade was a 11.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Bilal Muhsin sold 30,000 shares of Masimo stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the sale, the chief operating officer now directly owns 24,172 shares in the company, valued at $4,048,568.28. This represents a 55.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by company insiders.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.